Evidence map›Paper›PMID 32825505›Full record

ArticleMolecules (Basel, Switzerland)2020

The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells.

Nor Isnida Ismail, Iekhsan Othman, Faridah Abas, Nordin H Lajis, Rakesh Naidu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nor Isnida IsmailJeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia.
Iekhsan OthmanUniKL MESTECH, A1-1 Jalan TKS1, Taman Kajang Sentral, Kajang 43000, Malaysia.ORCID 0000-0001-9225-3678
Faridah AbasLaboratory of Natural Products, Faculty of Science, University Putra Malaysia, Serdang 43400, Malaysia.
Nordin H LajisLaboratory of Natural Products, Faculty of Science, University Putra Malaysia, Serdang 43400, Malaysia.
Rakesh NaiduJeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia.ORCID 0000-0003-0648-8898

Funding

Fundamental Research Grant Scheme, Ministry of Education, Malaysia FRGS/1/2016/SKK08/MUSM/02/1
6 · The paper itself

Abstract

The cytotoxic and apoptotic effects of turmeric (Curcuma longa) on colon cancer have been well documented but specific structural modifications of curcumin have been shown to possess greater growth-suppressive potential on colon cancer than curcumin. Therefore, the aim of this study is to identify the anti-cancer properties of curcumin analogue-MS13, a diarylpentanoid on the cytotoxicity, anti-proliferative and apoptotic activity of primary (SW480) and metastatic (SW620) human colon cancer cells. A cell viability assay showed that MS13 has greater cytotoxicity effect on SW480 (EC

Indexed as

Colonic NeoplasmsCurcuminCytotoxinsApoptosisCaspase 3Cell Line, TumorCell ProliferationHumansNeoplasm MetastasisProto-Oncogene Proteins c-bcl-2BCL2 protein, humanCASP3 protein, humanCaspase 3CurcuminCytotoxinsProto-Oncogene Proteins c-bcl-21,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-oneapoptosisBcl-2Caspase-3cell proliferationcolon cancercurcumin analoguediarylpentanoid (DAP)

Identifiers

PMID32825505
PMCPMC7504349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.